Experiment 243805

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

EUGLOBAL G-10

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismEucalyptus grandis (MYRTACEAE)
CitationUMEHARA,K: SINGH,IP: ETOH,H: TAKASAKI,M: KONOSHIMA,T:. (1998). FIVE PHLOROGLUCINOL-MONOTERPENE ADDUCTS FROM EUCALYPTUS GRANDIS.. 49(6)
Amount utilized
Compound isolated
Disease90% INHIBITON AT 1000 MOL RATIO/TPA WHILE MAINTAINING 70% VIABILITY OF THE RAJI CELLS.
Number6
Qualitative resultACTIVE
Dose expressionCONC USED